Martin Haverkamp
Chief Executive Officer & Co-founder
Former principal investigator in synthetic gene circuits. Founded Vitralis in 2019 after a decade building cell-free expression systems at the Halloway Institute of Technology.
Company
Leadership
The people building Vitralis.
Executive team
Dr. Marisol Ortega
Chief Scientific Officer & Co-founder
Protein engineer and architect of the Lumenfold design engine. Named inventor on 23 patents in directed evolution and enzyme stabilisation.
Lorenzo Castellano
Chief Financial Officer
Joined from Halcyon Ridge Capital, where he led life-science growth investments. Oversaw the Series B and C rounds.
Daniel Chen
VP, Bioprocess Engineering
Scaled continuous fermentation lines from bench to 20,000 L. Runs the Kestrel Bay pilot plant.
Dr. Ruth Ashdown
Head of Clinical & Regulatory Affairs
Leads the VitraGraft preclinical programme and regulatory strategy across three jurisdictions.
Siobhan Gallagher
Chief Information Security Officer
Protects Vitralis sequence libraries and lab automation networks. Speaks regularly on bio-cybersecurity.
Board of directors
JW
Jonathan Whitaker
Chair of the Board
Managing Partner, Halcyon Ridge Capital
PR
Dr. Priya Raman
Independent Director
Former Dean of Bioengineering, Aurel Harbour University
CN
Chidi Nwosu
Independent Director, Audit Committee Chair
Former CFO, Brightwater Diagnostics
SK
Sun-hee Kwon
Director
General Partner, Northfen Ventures
MH
Martin Haverkamp
Director
CEO, Vitralis Biotech